Patents by Inventor Yi Hong Wu

Yi Hong Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240332065
    Abstract: The present disclosure relates to a method of forming an interconnect structure that eliminates a separate deep via patterning process to simplify the fabrication process. In some embodiments, a first dielectric layer is formed over a first metal line and patterned to form a through-hole exposing a first contact region of the first metal line. A second dielectric layer is deposited and patterned to form a first via-hole connecting to the through-hole and a second via-hole exposing a second contact region of the second metal line from a layout view. A first via is formed on the first contact region extending to a first upper surface of the second dielectric layer, and a second via is formed on the second contact region extending to a second upper surface of the second dielectric layer.
    Type: Application
    Filed: March 28, 2023
    Publication date: October 3, 2024
    Inventors: Yao-Hong You, Dah-Chuen Ho, Kuo-Ming Wu, Ying-De Chen, Yi-Min Chen
  • Patent number: 12075613
    Abstract: A method for fabricating buried word line of a dynamic random access memory (DRAM) includes the steps of: forming a trench in a substrate; forming a first conductive layer in the trench; forming a second conductive layer on the first conductive layer, in which the second conductive layer above the substrate and the second conductive layer below the substrate comprise different thickness; and forming a third conductive layer on the second conductive layer to fill the trench.
    Type: Grant
    Filed: January 6, 2022
    Date of Patent: August 27, 2024
    Assignees: UNITED MICROELECTRONICS CORP., Fujian Jinhua Integrated Circuit Co., Ltd.
    Inventors: Pin-Hong Chen, Yi-Wei Chen, Tzu-Chieh Chen, Chih-Chieh Tsai, Chia-Chen Wu, Kai-Jiun Chang, Yi-An Huang, Tsun-Min Cheng
  • Publication number: 20240264405
    Abstract: An optical element driving mechanism is provided and includes a fixed assembly, a movable assembly, a driving assembly and a stopping assembly. The fixed assembly has a main axis. The movable assembly is configured to connect an optical element, and the movable assembly is movable relative to the fixed assembly. The driving assembly is configured to drive the movable assembly to move relative to the fixed assembly. The stopping assembly is configured to limit the movement of the movable assembly relative to the fixed assembly within a range of motion.
    Type: Application
    Filed: April 16, 2024
    Publication date: August 8, 2024
    Inventors: Chao-Chang HU, Liang-Ting HO, Chen-Er HSU, Yi-Liang CHAN, Fu-Lai TSENG, Fu-Yuan WU, Chen-Chi KUO, Ying-Jen WANG, Wei-Han HSIA, Yi-Hsin TSENG, Wen-Chang LIN, Chun-Chia LIAO, Shou-Jen LIU, Chao-Chun CHANG, Yi-Chieh LIN, Shang-Yu HSU, Yu-Huai LIAO, Shih-Wei HUNG, Sin-Hong LIN, Kun-Shih LIN, Yu-Cheng LIN, Wen-Yen HUANG, Wei-Jhe SHEN, Chih-Shiang WU, Sin-Jhong SONG, Che-Hsiang CHIU, Sheng-Chang LIN
  • Patent number: 11878009
    Abstract: The present invention relates to a combination of a histone deacetylase (HDAC) inhibitor, chidamide in an acidic salt form, and a nonsteroidal anti-inflammatory drugs (NSAIDs), celecoxib in a basic salt form. The present invention also relates to methods which significantly regulate tumor microenvironment and therefore dramatically improve anti-cancer activity.
    Type: Grant
    Filed: September 10, 2019
    Date of Patent: January 23, 2024
    Assignee: GREAT NOVEL THERAPEUTICS BIOTECH & MEDICALS CORPORATION
    Inventors: Jia-Shiong Chen, Mu-Hsuan Yang, Cheng-Han Chou, Yi-Hong Wu, Sz-Hao Chu, Ye-Su Chao, Chia-Nan Chen
  • Publication number: 20230263790
    Abstract: The present disclosure generally relates to compounds class I HDAC inhibitors, their production and applications. The compounds possess epigenetic immunomodulatory activities in the tumor microenvironment (TME) and thus inhibit growth of tumor cells.
    Type: Application
    Filed: May 1, 2023
    Publication date: August 24, 2023
    Inventors: Jia-Shiong CHEN, Mu-Hsuan YANG, Yi-Hong WU, Sz-Hao CHU, Cheng-Han CHOU, Ye-Su CHAO, Chia-Nan CHEN
  • Patent number: 11672788
    Abstract: The present disclosure generally relates to compounds class I HDAC inhibitors, their production and applications. The compounds possess epigenetic immunomodulatory activities in the tumor microenvironment (TME) and thus inhibit growth of tumor cells.
    Type: Grant
    Filed: April 28, 2021
    Date of Patent: June 13, 2023
    Assignee: Great Novel Therapeutics Biotech & Medicals Corporation
    Inventors: Jia-Shiong Chen, Mu-Hsuan Yang, Yi-Hong Wu, Sz-Hao Chu, Cheng-Han Chou, Ye-Su Chao, Chia-Nan Chen
  • Patent number: 11452754
    Abstract: Pharmaceutical compositions containing a combination of rhizoma coptidis and a herbal composition comprises at least one herb selected from the group consisting of Radix Ginseng, Poria, Rhizoma Atractylodis macrocephalae, Semen Lablab album, Rhizoma Dioscoreae, Embryo Nelumbinis, Radix Platycodonis, Semen Coicis, Fructus Amomi, Fructus Jujubae and Radix Glycyrrhizae are disclosed. Methods of treating diseases by administering an effective amount of the pharmaceutical composition are also provided.
    Type: Grant
    Filed: February 10, 2020
    Date of Patent: September 27, 2022
    Assignees: TAIPEI CHANG GUNG MEMORIAL HOSPITAL, CHANG GUNG UNIVERSITY
    Inventors: Yi-Hong Wu, Yueh Hsiang Huang, Jong-Hwei Su Pang
  • Publication number: 20220251218
    Abstract: The invention relates to a method of overcoming immune suppression in tumor microenvironment or stimulating immune response against cancer, comprising administering to a subject a combination of a histone deacetylase (HDAC) inhibitor and a tyrosine kinase inhibitor (TKI).
    Type: Application
    Filed: February 10, 2021
    Publication date: August 11, 2022
    Inventors: Cheng-Han CHOU, Yi-Hong WU, Jia-Shiong CHEN, Ye-Su CHAO, Chia-Nan CHEN
  • Publication number: 20210379032
    Abstract: The present disclosure generally relates to compounds class I HDAC inhibitors, their production and applications. The compounds possess epigenetic immunomodulatory activities in the tumor microenvironment (TME) and thus inhibit growth of tumor cells.
    Type: Application
    Filed: April 28, 2021
    Publication date: December 9, 2021
    Inventors: Jia-Shiong CHEN, Mu-Hsuan YANG, Yi-Hong WU, Sz-Hao CHU, Cheng-Han CHOU, Ye-Su CHAO, Chia-Nan CHEN
  • Publication number: 20210069163
    Abstract: The present invention relates to a combination of a histone deacetylase (HDAC) inhibitor, chidamide in an acidic salt form, and a nonsteroidal anti-inflammatory drugs (NSAIDs), celecoxib in a basic salt form. The present invention also relates to methods which significantly regulate tumor microenvironment and therefore dramatically improve anti-cancer activity.
    Type: Application
    Filed: September 10, 2019
    Publication date: March 11, 2021
    Inventors: Jia-Shiong CHEN, Mu-Hsuan YANG, Cheng-Han CHOU, Yi-Hong WU, Sz-Hao CHU, Ye-Su CHAO, Chia-Nan CHEN
  • Publication number: 20200268820
    Abstract: Pharmaceutical compositions containing a combination of rhizoma coptidis and a herbal composition comprises at least one herb selected from the group consisting of Radix Ginseng, Poria, Rhizoma Atractylodis macrocephalae, Semen Lablab album, Rhizoma Dioscoreae, Embryo Nelumbinis, Radix Platycodonis, Semen Coicis, Fructus Amomi, Fructus Jujubae and Radix Glycyrrhizae are disclosed. Methods of treating diseases by administering an effective amount of the pharmaceutical composition are also provided.
    Type: Application
    Filed: February 10, 2020
    Publication date: August 27, 2020
    Inventors: Yi-Hong WU, Yueh Hsiang HUANG, Jong-Hwei SU PANG
  • Patent number: 10688193
    Abstract: The invention provides a pH-sensitive linker that can simultaneously bind metallic nanoparticles and one or more agents with various molecular size. The linker of the invention can deliver the agents into cells involved in disease processes or close to cells so that the agents can selectively target and effect on the cells. The target delivery provided by the linker of the invention can be used for example for disease sensing, imaging, drug delivery, and therapy.
    Type: Grant
    Filed: July 21, 2016
    Date of Patent: June 23, 2020
    Assignee: GNT BIOTECH & MEDICALS CORPORATION
    Inventors: Yu-Jung Liao, Wei-Jan Huang, Chia-Nan Chen, Huan-Yu Lin, Ching-Yi Lin, Meng-Ju Tsai, Wan-Yi Hsu, Li-Ling Chi, Ye-Su Chao, Yi-Hong Wu
  • Publication number: 20180221498
    Abstract: The invention provides a pH-sensitive linker that can simultaneously bind metallic nanoparticles and one or more agents with various molecular size. The linker of the invention can deliver the agents into cells involved in disease processes or close to cells so that the agents can selectively target and effect on the cells. The target delivery provided by the linker of the invention can be used for example for disease sensing, imaging, drug delivery, and therapy.
    Type: Application
    Filed: July 21, 2016
    Publication date: August 9, 2018
    Inventors: Yu-Jung LIAO, Wei-Jan HUANG, Chia-Nan CHEN, Huan-Yu LIN, Ching-Yi LIN, Meng-Ju TSAI, Wan-Yi HSU, Li-Ling CHI, Ye-Su CHAO, Yi-Hong WU
  • Patent number: 7200096
    Abstract: A method and apparatus for modulating multilevel data arrays to make them suitable for storage in multidimensional storage media, such as in holographic storage. In order to get a uniform signal of constant energy at the recording plane, first the multilevel data array, Vout, displayed on a spatial light modulator, has frequent transitions between symbols of different levels, and second it has constant energy. The energy is defined as the summation of the values of the symbols in the data array. The first constraint is achieved using V?in=Vin?qM(q, ZO), where ?q stands for the modulo-q addition operation; M(q, Zo) is a data array with randomly distributed symbols of q levels, where q is the number of levels and ZO is the seed used to generate the random multilevel data array.
    Type: Grant
    Filed: August 17, 2001
    Date of Patent: April 3, 2007
    Assignee: Data Storage Institute
    Inventors: Cheng Chiang Phua, JingFeng Liu, Tow Chong Chong, Yi Hong Wu, Jun Li
  • Publication number: 20020051273
    Abstract: A method and apparatus for modulating multilevel data arrays to make them suitable for storage in multidimensional storage media, such as in holographic storage. In order to get a uniform signal of constant energy at the recording plane, first the multilevel data array, Vout, displayed on a spatial light modulator, has frequent transitions between symbols of different levels, and second it has constant energy. The energy is defined as the summation of the values of the symbols in the data array. The first constraint is achieved using V′in=Vin⊕qM (q, ZO), where ⊕q stands for the modulo-q addition operation; M(q, ZO) is a data array with randomly distributed symbols of q levels, where q is the number of levels and ZO is the seed used to generate the random multilevel data array.
    Type: Application
    Filed: August 17, 2001
    Publication date: May 2, 2002
    Inventors: Cheng Chiang Phua, JingFeng Liu, Tow Chong Chong, Yi Hong Wu, Jun Li